株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国における豚コレラワクチン産業の分析

Research Report on China Swine Fever Vaccine Industry, 2014-2018

発行 China Research and Intelligence 商品コード 288687
出版日 ページ情報 英文 50 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
中国における豚コレラワクチン産業の分析 Research Report on China Swine Fever Vaccine Industry, 2014-2018
出版日: 2014年09月17日 ページ情報: 英文 50 Pages
概要

中国は、世界最大の豚肉の生産国・消費国で、その生産量は全体のほぼ50%を占めています。豚コレラは、厳重な予防・管理・根絶を必要とする感染性の強い疾患だと考えられています。豚コレラワクチンは、豚に必要なワクチンの1つです。中国では、豚コレラワクチンの技術が成熟しているため、大規模な養豚場では、輸入ワクチンの代わりに、国産ワクチンを選択しています。

当レポートでは、中国の豚コレラワクチン産業について調査分析し、市場の状況、発展への影響要因、運営状況、主要メーカーなどについて、体系的な情報を提供しています。

第1章 世界と中国の豚コレラワクチン市場の状況

  • 豚コレラワクチンの関連概念
    • 豚コレラの定義
    • 豚コレラワクチンの定義
  • 豚コレラの概要
    • 豚コレラの発生状況
    • 中国の豚コレラの流行状況

第2章 中国における豚コレラワクチンの発展への影響要因

  • 中国の動物ワクチン産業の政策
    • 動物防疫に関する法律
    • 組織構造
    • 防疫の割当予算
    • 強制予防接種の範囲
    • 豚コレラの予防接種
  • 中国における養豚の概要
    • 豚の家畜頭数
    • 肥育豚の家畜頭数
    • 豚肉の生産量

第3章 中国の豚コレラワクチン産業の運営状況

  • 豚コレラワクチンの供給
    • 供給概要
    • 供給への影響要因
  • 需要
    • 需要概要
    • 需要への影響要因
  • 政府によって無償で提供される豚コレラワクチンの状況
    • 既存の問題の分析
    • 問題への解決策

第4章 中国における豚コレラワクチンの主要メーカー

  • 企業プロファイル、生産状況、開発戦略
    • Guangdong Winsun Pharmaceutical Co., Ltd.
    • Guangdong Dahuanong Animal Health Products Co., Ltd.
    • Liaoning Yikang Biology Co., Ltd.
    • China Animal Husbandry Industry Co., Ltd. (CAHIC)

第5章 中国における一部の地方自治体による豚コレラワクチン購入の状況

  • 山東省における豚コレラワクチンの落札状況
  • 山西省における豚コレラワクチンの落札状況

第6章 中国における豚コレラワクチン産業の見通し

  • 発展への影響要因
  • 需給予測

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 1409174

China is the world's largest producer and consumer of pork with the output volume accounting nearly 50% of the total. The output volume of pork was 54.93 million tons in China in 2013, up by 2.8% YOY. The livestock volume of pigs was 474.11 million, down by 0.4% YOY while the stock volume of fattened pigs was 715.57 million, up by 2.5% YOY.

Swine fever is considered a highly infectious disease that needs strict prevention, control and extermination. The swine fever vaccine is one of the necessary vaccines for pigs. Due to the mature technology of swine fever vaccines in China, most large-scale pig farms choose domestic vaccines instead of imported vaccines. There are 48 manufacturers of spleen neisseria vaccines and cell vaccines in China, including 32 for the former and 41 for the latter. Passaging cell vaccines used to be produced by Guangdong Winsun Pharmaceutical Co., Ltd. Through technology transfer, Dahuanong and Liaoning Yikang Biology Co.,Ltd. began to produce the products while Guangdong Winsun still leads in the industry.

According to the National Compulsory Immunization Plan of Animal Epidemic Diseases in China in 2013 issued by the Ministry of Agriculture of China, China implements compulsory immunity on four animal epidemic diseases including swine fever while the expenses on the vaccines are undertaken by the government.

With the increasing living standards of Chinese people, the demand for poultry meat keeps growing accordingly. However, as swine fever repeatedly occurs in China, either regional outbreak or scattered transmission, most of the cases are acute epidemic situations with high mortality rate. Meanwhile, some features of mild diseases add to the complexity of the swine fever epidemic situation. Under the circumstances, swine fever vaccines become increasingly popular while many competitive vaccine manufacturers began to develop more effective swine fever vaccines.

As Chinese economy develops and the living standards increase, the demand for pork will continue to grow, which promotes the development of pig raising industry. The market size of swine fever vaccines will continue to increase in China in the next few years. Many investment opportunities exist in China for manufacturers of animal vaccines.

Through this report, the readers can acquire the following information:

  • Incidence Status of Swine Fever
  • Status of China Breeding Industry
  • Policy Environment and Government Procurement of Swine Fever Vaccines in China
  • Status of Supply and Demand for Swine Fever Vaccines in China
  • Major Manufacturers of Swine Fever Vaccines and the Operation Status in China
  • Prospect of China Swine Fever Vaccine Industry

The Following Enterprises and People Are Recommended to Purchase This Report:

  • Manufacturers and Trading Enterprises of Animal Vaccines
  • Breeding Enterprises
  • Management Organizations of Livestock Industry
  • Investors and Research Institutes Concerned about Swine Fever Vaccine Industry

Table of Contents

1. Status of Global and China Swine Fever Vaccine Market

  • 1.1. Relevant Concepts of Swine Fever Vaccines
    • 1.1.1. Definition of Swine Fever

1.1. Definition of Swine Fever Vaccines

  • 1.2. Brief Introduction of Swine Fever
    • 1.2.1. Incidence Status of Swine Fever
    • 1.2.2. Epidemic Situation of Swine Fever in China

2. Factors Influencing Development of Swine Fever Vaccine Industry in China, 2009-2014

  • 2.1. Policies in China Animal Vaccine Industry
    • 2.1.1. Legislation of Animal Epidemic Prevention
    • 2.1.2. Organization Structure
    • 2.1.3. Appropriation Budget of Epidemic Prevention
    • 2.1.4. Scope of Compulsory Immunization
    • 2.1.5. Swine Fever Immunization Policies
  • 2.2. Overview of Pig Breeding in China, 2009-2013
    • 2.2.1. Livestock Volume of Pigs
    • 2.2.2. Stock Volume of Fattened Pigs
    • 2.2.3. Output Volume of Pork

3. Operation Status of Swine Fever Vaccine Industry in China, 2009-2013

  • 3.1. Supply of Swine Fever Vaccines
    • 3.1.1. Supply Overview
    • 3.1.2. Factors Influencing Supply
  • 3.2. Demand
    • 3.2.1. Demand Overview
    • 3.2.2. Factors Influencing Demand
  • 3.3. Status of Free Swine Fever Vaccines Provided by Government
    • 3.3.1. Analysis of Existing Problems
    • 3.3.2. Solutions to Problems

4. Major Manufacturers of Swine Fever Vaccines in China, 2011-2013

  • 4.1. Guangdong Winsun Pharmaceutical Co., Ltd.
    • 4.1.1. Enterprise Profile
    • 4.1.2. Production Status of Swine Fever Vaccines
    • 4.1.3. Development Strategies of the Enterprise
  • 4.2. Guangdong Dahuanong Animal Health Products Co., Ltd.
    • 4.2.1. Enterprise Profile
    • 4.2.2. Production Status of Swine Fever Vaccines
    • 4.2.3. Development Strategies
  • 4.3. Liaoning Yikang Biology Co., Ltd.
    • 4.3.1. Enterprise Profile
    • 4.3.2. Production Status of Swine Fever Vaccines
    • 4.3.3. Development Strategies
  • 4.4. China Animal Husbandry Industry Co., Ltd. (CAHIC)
    • 4.4.1. Enterprise Profile
    • 4.4.2. Production Status of Swine Fever Vaccines
    • 4.4.3. Development Strategies

5. Status of Swine Fever Vaccine Purchase by Some Local Governments in China, 2013-2014

  • 5.1. Bid Winning Status of Swine Fever Vaccines in Shandong, 2013-2014
    • 5.1.1. Bid Winning Enterprises and Products of Swine Fever Vaccines
    • 5.1.2. Bid Winning Prices
  • 5.2. Bid Winning Status of Swine Fever Vaccines in Shanxi, 2013-2014
    • 5.2.1. Bid Winning Enterprises and Products of Swine Fever Vaccines
    • 5.2.2. Bid Winning Prices

6. Prospect of China Swine Fever Vaccine Industry, 2014-2018

  • 6.1. Factors Influencing Development
    • 6.1.1. Government Policies
    • 6.1.2. Pig Breeding
  • 6.2. Forecast on Supply and Demand
    • 6.2.1. Forecast on Supply of Swine Fever Vaccines
    • 6.2.2. Forecast on Demand for Swine Fever Vaccines

Selected Charts

  • Chart Epidemic Situation of Swine Fever in China, 2012-2014
  • Chart Expenses of Chinese Government on Animal Epidemic Prevention, 2009-2014
  • Chart Volume of Fattened Pigs in China, 2009-2013
  • Chart Major Types of Swine Fever Vaccines in China
  • Chart Market Size of Swine Fever Vaccines in China, 2009-2013
  • Chart Forecast on Output Volume of Swine Fever Vaccines in China, 2014-2018
  • Chart Forecast on Market Size of Swine Fever Vaccines in China, 2014-2018
Back to Top